Filing Details

Accession Number:
0001209191-22-018221
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-11 17:17:40
Reporting Period:
2022-03-11
Accepted Time:
2022-03-11 17:17:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1349376 P Timothy Walbert C/O Horizon Therapeutics Plc,
70 Saint Stephen?S Green
Dublin L2 D02 E2X4
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-03-11 25,000 $22.14 560,549 No 4 M Direct
Ordinary Shares Disposition 2022-03-11 18,338 $100.77 542,211 No 4 S Direct
Ordinary Shares Disposition 2022-03-11 6,662 $101.38 535,549 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2022-03-11 25,000 $0.00 25,000 $22.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
892,565 2025-03-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 107,739 Indirect See footnote
Ordinary Shares 100,300 Indirect See footnote
Ordinary Shares 40,923 Indirect By spouse
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.18 to $101.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.19 to $101.72 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
  5. The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
  6. The stock option is fully vested and exercisable.